Literature DB >> 18201700

Focus on molecules: gremlin.

Robert J Wordinger1, Gulab Zode, Abbot F Clark.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 18201700      PMCID： PMC2649704          DOI： 10.1016/j.exer.2007.11.016

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN： 0014-4835            Impact factor:   3.467


× No keyword cloud information.
  4 in total

Review 1.  Bone morphogenetic proteins and their receptors in the eye.

Authors:  Robert J Wordinger; Abbot F Clark
Journal:  Exp Biol Med (Maywood)       Date:  2007-09

2.  Gremlin gene expression in bovine retinal pericytes exposed to elevated glucose.

Authors:  R Kane; L Stevenson; C Godson; A W Stitt; C O'Brien
Journal:  Br J Ophthalmol       Date:  2005-12       Impact factor: 4.638

3.  Effects of TGF-beta2, BMP-4, and gremlin in the trabecular meshwork: implications for glaucoma.

Authors:  Robert J Wordinger; Debra L Fleenor; Peggy E Hellberg; Iok-Hou Pang; Tara O Tovar; Gulab S Zode; John A Fuller; Abbot F Clark
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-03       Impact factor: 4.799

4.  The role of gremlin, a BMP antagonist, and epithelial-to-mesenchymal transition in proliferative vitreoretinopathy.

Authors:  Helena Lee; Sarah J O'Meara; Colm O'Brien; Rosemary Kane
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-09       Impact factor: 4.799
  4 in total
  23 in total

Review 1.  Bone morphogenetic proteins and their antagonists: current and emerging clinical uses.

Authors:  Imran H A Ali; Derek P Brazil
Journal:  Br J Pharmacol       Date:  2014-08       Impact factor: 8.739

2.  SFRP1 promoter methylation and expression in human trabecular meshwork cells.

Authors:  Weiming Mao; Jeffrey S Rubin; Nancy Anoruo; Robert J Wordinger; Abbot F Clark
Journal:  Exp Eye Res       Date:  2012-01-09       Impact factor: 3.467

3.  Role of TGFbeta/Smad signaling in gremlin induction of human trabecular meshwork extracellular matrix proteins.

Authors:  Anirudh Sethi; Ankur Jain; Gulab S Zode; Robert J Wordinger; Abbot F Clark
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-07-15       Impact factor: 4.799

4.  Genetic heterogeneity in colorectal cancer associations between African and European americans.

Authors:  Sonia S Kupfer; Jeffrey R Anderson; Stanley Hooker; Andrew Skol; Rick A Kittles; Temitope O Keku; Robert S Sandler; Nathan A Ellis
Journal:  Gastroenterology       Date:  2010-07-24       Impact factor: 22.682

5.  Gremlin utilizes canonical and non-canonical TGFβ signaling to induce lysyl oxidase (LOX) genes in human trabecular meshwork cells.

Authors:  Anirudh Sethi; Robert J Wordinger; Abbot F Clark
Journal:  Exp Eye Res       Date:  2013-06-05       Impact factor: 3.467

6.  Common genetic variants (rs4779584 and rs10318) at 15q13.3 contributes to colorectal adenoma and colorectal cancer susceptibility: evidence based on 22 studies.

Authors:  Lin Tu; Bin Yan; Zhiyong Peng
Journal:  Mol Genet Genomics       Date:  2014-12-05       Impact factor: 3.291

Review 7.  Beyond the bone: Bone morphogenetic protein signaling in adipose tissue.

Authors:  Ana M Blázquez-Medela; Medet Jumabay; Kristina I Boström
Journal:  Obes Rev       Date:  2019-01-04       Impact factor: 9.213

Review 8.  Regulation of the ovarian reserve by members of the transforming growth factor beta family.

Authors:  Stephanie A Pangas
Journal:  Mol Reprod Dev       Date:  2012-09-11       Impact factor: 2.609

9.  Identification of Diabetic Retinopathy Genes through a Genome-Wide Association Study among Mexican-Americans from Starr County, Texas.

Authors:  Yi-Ping Fu; D Michael Hallman; Victor H Gonzalez; Barbara E K Klein; Ronald Klein; M Geoffrey Hayes; Nancy J Cox; Graeme I Bell; Craig L Hanis
Journal:  J Ophthalmol       Date:  2010-09-02       Impact factor: 1.909

10.  Existence of the canonical Wnt signaling pathway in the human trabecular meshwork.

Authors:  Weiming Mao; J Cameron Millar; Wan-Heng Wang; Sean M Silverman; Yang Liu; Robert J Wordinger; Jeffrey S Rubin; Iok-Hou Pang; Abbot F Clark
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-10-09       Impact factor: 4.799
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.